Your browser doesn't support javascript.
loading
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Perez, Kimberly; Chiarella, Anna M; Cleary, James M; Horick, Nora; Weekes, Colin; Abrams, Thomas; Blaszkowsky, Lawrence; Enzinger, Peter; Giannakis, Marios; Goyal, Lipika; Meyerhardt, Jeffrey A; Rubinson, Douglas; Yurgelun, Matthew B; Goessling, Wolfram; Giantonio, Bruce J; Brais, Lauren; Germon, Victoria; Stonely, Danielle; Raghavan, Srivatsan; Bakir, Basil; Das, Koushik; Pitarresi, Jason R; Aguirre, Andrew J; Needle, Michael; Rustgi, Anil K; Wolpin, Brian M.
Afiliação
  • Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chiarella AM; Harvard Medical School, Boston, MA, USA.
  • Cleary JM; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Horick N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Weekes C; Harvard Medical School, Boston, MA, USA.
  • Abrams T; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
  • Blaszkowsky L; Harvard Medical School, Boston, MA, USA.
  • Enzinger P; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Goyal L; Harvard Medical School, Boston, MA, USA.
  • Meyerhardt JA; Harvard Medical School, Boston, MA, USA.
  • Rubinson D; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Goessling W; Harvard Medical School, Boston, MA, USA.
  • Giantonio BJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Brais L; Harvard Medical School, Boston, MA, USA.
  • Germon V; Harvard Medical School, Boston, MA, USA.
  • Stonely D; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bakir B; Harvard Medical School, Boston, MA, USA.
  • Das K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pitarresi JR; Harvard Medical School, Boston, MA, USA.
  • Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Needle M; Harvard Medical School, Boston, MA, USA.
  • Rustgi AK; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Wolpin BM; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Oncologist ; 28(5): 425-432, 2023 05 08.
Article em En | MEDLINE | ID: mdl-36807743
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Hipoalbuminemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Hipoalbuminemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article